Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Evidence- |
RCV000495795 | SCV000578400 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 1 | 2017-06-29 | reviewed by expert panel | curation | Synonymous substitution variant, with low bioinformatic likelihood to result in a splicing aberration (Splicing prior probability 0.02; http://priors.hci.utah.edu/PRIORS/). |
Ambry Genetics | RCV000163573 | SCV000214132 | likely benign | Hereditary cancer-predisposing syndrome | 2016-02-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000205054 | SCV000261539 | likely benign | Hereditary breast ovarian cancer syndrome | 2025-01-23 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000163573 | SCV000537487 | likely benign | Hereditary cancer-predisposing syndrome | 2015-07-22 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000587737 | SCV000699179 | likely benign | not specified | 2019-08-21 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000495795 | SCV004817620 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 1 | 2023-04-03 | criteria provided, single submitter | clinical testing |